PPARGC1A and hepatocellular carcinoma: Reduced PGC1α activity has been found to be associated with downregulation of CPT1A and acyl-CoA oxidase 1 (ACOX1) and inhibition of FAO in HCC cells (53), both contributing to HCC growth and metastasis (69, 70).